Critical Mass Radio Show

Dr. Sanjay Shrivastava is the founder and CEO of Innova Vascular, Inc., a company engaged in developing innovative cardiovascular medical devices. Prior to founding Innova, Sanjay cofounded BlackSwan Vascular, which is a medical device startup company that developed the first liquid embolic agent approved for a peripheral vascular use in the USA and has a strategic alliance with Sirtex Medical Limited. Sanjay also serves as a member of the board of directors at enVVeno Medical Corporation, which is a Nasdaq traded medical device company headquartered in Irvine, CA. Sanjay has been involved in developing, commercializing, evaluating, and acquiring medical devices for over 20 years. During his career, Sanjay has held positions at leading medical device companies including senior director, business development at Johnson & Johnson, vice president, upstream marketing and strategy at BTG, plc. (a publicly traded company that was acquired by Boston Scientific Corporation), director global marketing at Medtronic